Ufp Technologies (UFPT) Capital Expenditures (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Capital Expenditures came in at $1.2 million in Q2 2026, down 59.4% on a YoY basis from $2.9 million in Q2 2025, and down 33.56% quarter-over-quarter from $1.7 million in Q1 2026.
Analysis
Ufp Technologies (UFPT) Capital Expenditures (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has reported Capital Expenditures for 17 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Capital Expenditures fell 59.4% year-over-year to $1.2 million; the trailing twelve-month figure through Jun 2026 stood at $10.2 million (down 6.18% YoY), and the FY2025 full-year result was $12.9 million, up 33.86% from the prior year.
- Capital Expenditures declined to $1.2 million in Q2 2026 per UFPT's latest filing, from $1.7 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $6.2 million in Q2 2022 and bottomed at $1.2 million in Q2 2026.
- Historically, Capital Expenditures has averaged $2.8 million across 5 years, with a median of $2.8 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Capital Expenditures surged 236.5% in 2022, then slumped 59.4% in 2026.
- Over 5 years, Capital Expenditures stood at $3.0 million in 2022, then slipped by 7.02% to $2.8 million in 2023, then increased by 9.11% to $3.0 million in 2024, then gained by 28.83% to $3.9 million in 2025, then plunged by 70.06% to $1.2 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $1.2 million, $1.7 million, and $3.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 112.60 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 503.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 202.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 195.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 66.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -96.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 84.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Ufp Technologies | 2.15 Bn | 2.14 Bn | 50.92 Mn | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.75 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.38 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 2.76 Mn |
| Sep 30, 2023 | 2.78 Mn |
| Jun 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 2.96 Mn |
| Sep 30, 2022 | 2.31 Mn |
| Jun 30, 2022 | 6.17 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Dec 31, 2021 | 1.12 Mn |
| Sep 30, 2021 | 995,000.00 |